Glutathione Derivatives as Potential Drugs for Colorectal Cancer Resulted by APC Mutations

2019 ◽  
Vol 12 (8) ◽  
pp. 3911
Author(s):  
Sneha James ◽  
P K Krishnan Namboori ◽  
Leena K Pappachen
2006 ◽  
Vol 136 (12) ◽  
pp. 3015-3021 ◽  
Author(s):  
Stefan de Vogel ◽  
Manon van Engeland ◽  
Margreet Lüchtenborg ◽  
Adriaan P. de Bruïne ◽  
Guido M. J. M. Roemen ◽  
...  

2017 ◽  
Vol 16 (4) ◽  
pp. 752-762 ◽  
Author(s):  
Noritaka Tanaka ◽  
Tetsuo Mashima ◽  
Anna Mizutani ◽  
Ayana Sato ◽  
Aki Aoyama ◽  
...  

2000 ◽  
Vol 157 (2) ◽  
pp. 185-191 ◽  
Author(s):  
Yoshimitsu Akiyama ◽  
Hiromi Nagasaki ◽  
Kenji Osmar Yagi ◽  
Tadashi Nomizu ◽  
Yasuhito Yuasa

Gut ◽  
1997 ◽  
Vol 41 (2) ◽  
pp. 235-238 ◽  
Author(s):  
N E Beck ◽  
I P M Tomlinson ◽  
T F R Homfray ◽  
I M Frayling ◽  
S V Hodgson ◽  
...  

Background—The hereditary non-polyposis colorectal cancer (HNPCC) syndrome is caused by germline mutations in mismatch repair genes and predisposes individuals to cancers of the colon and other specific sites. On theoretical grounds, it is expected that patients with HNPCC also develop more colorectal adenomas than the general population. In essence, if the mutation rate is raised owing to mutations at a mismatch repair locus, more mutations are expected at loci such as APC (adenomatous polyposis coli) and more adenomas will start to grow. Not all data support this expectation, however.Aim—To search for germline mutations at HNPCC loci in patients with multiple adenomas.Subjects—Twenty five patients (without known APC mutations) who have developed colorectal adenomas in unusually large numbers and, in some cases, at an early age.Methods—Germline APC mutations were excluded using the protein truction test for exon 15 and mismatch chemical cleavage analysis for remaining exons. Germline HNPCC mutations were detected by using PCR and single strand conformation polymorphism analysis.Results—Just one germline HNPCC mutation was found (4% of cases) and this was of uncertain functional effect.Conclusions—In general, germline HNPCC mutations are not responsible for the phenotype of patients with multiple colonic adenomas. It is possible that patients with HNPCC tend to develop adenomas more frequently and earlier than the general population, but that this effect is relatively subtle. These results suggest that individuals with colorectal adenomas only should not strictly be classified as “affected” in HNPCC families (although they should certainly not be classified as “unaffected” either and may warrant intensive screening). In the absence of a personal or strong family history of colorectal cancer, it is probably not worthwhile performing diagnostic or predictive genetic testing for HNPCC mutations in subjects with colorectal adenomas. Although undetected APC mutations may be responsible for some of the phenotypes in this sample, as yet uncharacterised adenoma predisposing genes probably exist.


2019 ◽  
Vol 9 (10) ◽  
pp. 1358-1371 ◽  
Author(s):  
Emma M. Schatoff ◽  
Sukanya Goswami ◽  
Maria Paz Zafra ◽  
Miguel Foronda ◽  
Michael Shusterman ◽  
...  

2006 ◽  
Vol 906 (1) ◽  
pp. 44-50 ◽  
Author(s):  
CHRISTOPHER D. GOCKE ◽  
FLOYD A. BENKO ◽  
MICHAEL S. KOPRESKI ◽  
THOMAS J. McGARRITY

2014 ◽  
Vol 146 (5) ◽  
pp. S-322-S-323
Author(s):  
Hassan Ashktorab ◽  
Joseph Devaney ◽  
Sudhir Varma ◽  
Mohammad Daremiporan ◽  
Edward L. Lee ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (8) ◽  
pp. 1883
Author(s):  
Yuan-Tzu Lan ◽  
Shih-Ching Chang ◽  
Pei-Ching Lin ◽  
Chun-Chi Lin ◽  
Hung-Hsin Lin ◽  
...  

Background: Few reports have investigated genetic alterations between patients with early and late recurrence following curative surgery for colorectal cancer (CRC). Methods: A total of 1227 stage I–III CRC patients who underwent curative resection were included retrospectively. Among them, 236 patients had tumor recurrence: 139 had early (<2 years after surgery) and 97 had late (≥2 years after surgery) recurrence. Clinicopathological features and genetic alterations were compared between the two groups. Results: Compared to those with late recurrence, patients with early recurrence were more likely to have advanced pathological node (N) categories; tumor, node, metastasis (TNM) stages; adjuvant chemotherapy treatment; liver metastases; APC mutations; and worse five-year overall survival rates. Patients with right-sided colon cancer were more likely to develop early recurrence than were those with left-sided colon cancer or rectal cancer. Regarding rectal cancer, patients with early recurrence were more likely to be at advanced pathological N categories and TNM stages than those with late recurrence. Multivariate analysis revealed old age, early recurrence, multiple-site recurrence, and BRAF and NRAS mutations to be independent prognostic factors. Conclusion: CRC patients with early recurrence have a worse OS rate and more APC mutations than those with late recurrence.


Sign in / Sign up

Export Citation Format

Share Document